Biosimilars: How Much Entry and Price Competition Will Result?
J. Mestre-Ferrandiz and
in Monographs from Office of Health Economics
This publication reports on a seminar intended to encourage further thought about the distinguishing characteristics of the market for biosimilars and the implications of these for potential savings. Economists and regulatory experts from the US and Europe were invited to describe their research and offer their perspectives about what can be expected in the near- and medium-term. The publication includes updated insights that take account of changes since the seminar, including more recent analyses of potential market impact. Chapter authors include Profs Bengt Jönsson (Stockholm School of Economics), Prof Henry Grabowski (Duke University), Prof Adrian Towse and Dr. Jorge Mestre-Ferrandiz (OHE), Prof Richard G. Frank (Harvard Medical School / US Department of Health and Human Services), Dr. Gopalan Narayanan (UK MHRA Biologicals and Technology Unit), Dr. Matthias Liefner (Simon Kucher) and Alexis Ahlstrom (Avalere Health / US Department of Health and Human Services).
Keywords: Economics; of; Industry (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
References: Add references at CitEc
Citations: View citations in EconPapers (1) Track citations by RSS feed
Downloads: (external link)
https://www.ohe.org/system/files/private/publicati ... ry%20and%20price.pdf (application/pdf)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:ohe:monogr:000195
Access Statistics for this book
More books in Monographs from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ().